Overview
Pulmonary aspergillosis encompasses a spectrum of diseases caused by the fungus Aspergillus, ranging from allergic bronchopulmonary aspergillosis to invasive aspergillosis, with chronic necrotizing aspergillosis being a severe form characterized by progressive lung tissue necrosis 1.Diagnosis
Clinical Presentation: Chronic cough, hemoptysis, and constitutional symptoms like weight loss 1.
Imaging: Chest CT showing characteristic nodules, cavitation, or reticulonodular opacities 1.
Microbiology: Bronchoalveolar lavage or tissue biopsy with Aspergillus hyphae identification 1.
Serology: Not typically useful for chronic necrotizing disease; more relevant for allergic forms 1.Management
First-line Treatment: Itraconazole, effective in managing chronic necrotizing forms 1.
Adjunctive Therapies: Surgical resection may be considered for localized disease refractory to medical therapy 1.
Monitoring: Regular imaging and clinical follow-up to assess response and recurrence 1.Special Populations
Comorbidities: Patients with underlying conditions like ankylosing spondylitis may be at higher risk 1.Key Recommendations
Initiate itraconazole for chronic necrotizing pulmonary aspergillosis, demonstrating efficacy in managing the condition (Evidence: Moderate 1).
Consider surgical intervention for localized disease unresponsive to antifungal therapy (Evidence: Expert opinion 1).
Regular monitoring through imaging and clinical assessment is crucial for disease progression and treatment response (Evidence: Expert opinion 1).References
1 Elliott JA, Milne LJ, Cumming D. Chronic necrotising pulmonary aspergillosis treated with itraconazole. Thorax 1989. link